TTrialPathMatch Me to Trials
← Back to trials
RecruitingUrinary Incontinence, StressOverweight and/or Obesity

A Study to Learn About the Safety and Effectiveness of Berobenatide in Women With Urine Leakage and With Obesity or Overweight (VESPER-SUI)

Eligible age

18+ yrs

Accepts

Women

Locations

6 states

Healthy volunteers

No

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

The purpose of this study is to learn about the safety and effectiveness of berobenatide in adult women who have both stress urinary incontinence (SUI) and obesity or overweight. Participants will be in the study for about 63 weeks

Sponsor: Pfizer

You may qualify if…

  • ✓ Adult women aged 18 years or older
  • ✓ Body mass index (BMI) of 27 kg/m² or greater
  • ✓ Have a diagnosis of stress urinary incontinence
  • ✓ Willing and able to comply with study procedures

You may not qualify if…

  • ✕ Have had urinary incontinence surgery
  • ✕ Have taken medications (prescribed or over-the counter) intended to promote weight loss within 90 days prior to randomization
  • ✕ Have recently received onabotulinumtoxin A (Botox) bladder injections or currently taking medications for urinary incontinence
  • ✕ History of acute or chronic pancreatitis
  • ✕ Personal or family history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia type 2 (MEN-2)
  • ✕ Have diabetes or laboratory assessments indicative of diabetes
  • ✕ Have had a cardiovascular health condition within 90 days prior to randomization
  • ✕ Are breastfeeding, pregnant, parturition in the past 12 months, planning to become pregnant in the following 12 months, or of childbearing potential and not using adequate contraception

Where it's recruiting

California

Citrus Heights · Sacramento

Florida

Boynton Beach · Miami

New Jersey

Warren Township

Texas

Houston

Washington

Bellevue

Source: ClinicalTrials.gov · NCT07932925 · last updated 2026-11-19

A Study to Learn About the Safety and Effectiveness of Berobenatide in · TrialPath